Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Casirivimab Emergency use authorization Experimental Antiviral Jan/23/2023 27 16
Imdevimab Emergency use authorization Experimental Antiviral Jan/23/2023 32 11
T cells Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/18/2023 24 0
Remdesivir Approved by FDA Experimental Antiviral Jan/18/2023 73 5
Regdanvimab Authorized Experimental Antiviral Jan/18/2023 6 4
Mesenchymal stem cells Potential treatment - clinical evidence Experimental Other treatment Oct/17/2022 63 3
Anti-spike nanobody-IFN-β conjugated exosomes Potential treatment - pre-clinical evidence Experimental Antiviral Sep/26/2022 1 0
IMAT-MSCs Potential treatment - pre-clinical evidence Experimental Other treatment Sep/23/2022 1 0
Exosomal vaccine Potential treatment - pre-clinical evidence Experimental Vaccine Jul/29/2022 2 0
Sotrovimab Emergency use authorization Experimental Antiviral Jul/14/2022 7 2
Excel (.xslx) CSV (.csv)